Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study

Background: Bevacizumab was demonstrated to have efficacy in patients with NSCLC. However, application of different doses of bevacizumab in different clinical trials was overlooked. This study aims to investigate the effects and safety of different doses of bevacizumab in the treatment.Methods: From...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chun-Hua Zhou, Feng Yang, Wen-Juan Jiang, Yong-Chang Zhang, Hai-Yan Yang, Liang Zeng, Li Liu, Yi Xiong, Fan-Xu Zeng, Zhan Wang, Nong Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
bevacizumab
chemotherapy
different dose
efficacy and safety
NSCLC
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/7acdcf1b87e249ddb0fe46e0a95b3d71
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares